|
|
Volumn 66, Issue 21, 2009, Pages 1890-
|
|
FDA approves pralatrexate for treatment of rare lymphoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYANOCOBALAMIN;
FOLIC ACID;
FOLOTYN;
PRALATREXATE;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
DRUG DOSE REDUCTION;
DRUG LABELING;
DRUG MARKETING;
FATIGUE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MEDICAL SOCIETY;
MUCOSA INFLAMMATION;
NAUSEA;
NOTE;
OPEN STUDY;
PRIORITY JOURNAL;
SIDE EFFECT;
T CELL LYMPHOMA;
THROMBOCYTE COUNT;
TUMOR VOLUME;
|
|
EID: 70449688130
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news090080 Document Type: Note |
|
Times cited : (23)
|
|
References (0)
|